Bronhalis-Heel (50 tablets)

The instruction for medical use of BRONHALIS-HEEL medicine the Trade name of BRONHALIS-HEEL the International unlicensed name Is not present the Dosage form of the Tablet Structure One Tablet contains active agents: Atropa bella-donna D4 of 30.0 mg Bryonia D4 of 60.0 mg Hyoscyamus niger D4 of 60.0 mg Kalium stibyltartaricum D4 of 30.0 mg Kreosotum D5 of 30.0 mg Lobelia inflata D4 of 30.0 mg Lobaria pulmonaria D4 of 30.0 mg Psychotria ipecacuanha D4 of 30.0 mg excipient - magnesium stearate. The description of the Tablet of round shape, with a flat surface, from white till ochroleucous color, with a facet, with a creosote smell. After storage from time to time flavourless. Pharmacotherapeutic group Other combinations of drugs for elimination of symptoms of cold. The ATX R05X code the Pharmacological Pharmacokinetics to Investigate properties pharmacokinetic properties of homeopathic medicines is not possible. The pharmacodynamics Bronkhalis-Heel – homeopathic medicine, renders anti-inflammatory, expectorant, broncholitic, antibechic, immunomodulatory action. Influence of drug is based on activation of protective forces of an organism and normalization of the broken functions at the expense of substances of plant and mineral origin which are a part of drug. Indications - acute and chronic bronchitis, including a catarrhal bronchitis of the smoker the Route of administration and doses the Single dose: to adults and children of 6 years - 1 tablet under language sublingual (before full resorption), to children is from 3 to 6 years – ½ tablets, the water pounded in powder and dissolved in 1 teaspoon. To accept 3 times a day in 15-20 min. prior to food or in 1 hour after a meal. In case of acute onset of a disease to accept a single dose each 15 minutes for 2 hours. Further to pass to reception 3 times a day. A course of treatment – 2-4 weeks. The doctor can reduce reception frequency to 1-2 times a day and if necessary repeat a course of treatment in 2-3 weeks. Side effects - allergic reactions owing to individual hypersensitivity to Contraindication drug components - hypersensitivity to drug components Medicinal interactions Drug is compatible to other medicines. Special instructions in the course of production of drug lactose is used therefore patients with a lactose intolerance, deficiency of Lapp-lactases enzyme and malabsorption of glucose galactose should not use drug. Use in pediatrics Experience of use of this drug by children up to 3 years has no sufficient documentary confirmation therefore children of this age group should not take the drug. To Apply pregnancy and the period of a lactation only after preliminary consultation with the doctor. The feature of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms does not affect ability to run the vehicle or potentially dangerous mechanisms. Overdose Cases of overdose of drug are not described. The form of release and packing On 50 tablets place in a polypropylene container with a cover stopper from polypropylene. On 1 container together with the instruction for medical use in the state and Russian languages put in a pack from cardboard. To Store storage conditions in original packing at a temperature from 9 °C to 29 °C. To store out of children's reach! Not to apply a period of storage of 5 years after the expiry date specified on packing! Prescription status Without prescription of Proizvoditel Biologishe Haylmittel Heel GmbH Dr. Rekeveg strasse 2-4, 76532 Baden-Baden, Germany the Owner of the registration certificate of Biologishe Haylmittel Heel GmbH Dr. Rekeveg strasse 2-4, 76532 Baden-Baden, Germany the Address of the organization in the territory of the Republic of Kazakhstan: the accepting claim (offer) on quality of medicines from consumers, responsible for post-registration observation of safety of medicine of AEM Services LLP 050040, RK, Almaty, Al-Farabi Ave., 75A, office 102-103 of aemservices@mail.ru +7 707 798 83 83